摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-PtCl2(3-pyridinecarboxylic acid)2 | 41637-07-4

中文名称
——
中文别名
——
英文名称
cis-PtCl2(3-pyridinecarboxylic acid)2
英文别名
cis-[PtCl2(3-pycaH)2];Dichloroplatinum;pyridine-3-carboxylic acid
cis-PtCl2(3-pyridinecarboxylic acid)2化学式
CAS
41637-07-4
化学式
C12H10Cl2N2O4Pt
mdl
——
分子量
512.208
InChiKey
FGCOPWUBNBYDPO-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.94
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    100
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    烟酸potassium tetrachloroplatinate(II)甲醇 为溶剂, 以69%的产率得到cis-PtCl2(3-pyridinecarboxylic acid)2
    参考文献:
    名称:
    Novel platinum pyridinehydroxamic acid complexes: Synthesis, characterisation, X-ray crystallographic study and nitric oxide related properties
    摘要:
    Herein, we describe the synthesis and characterisation of a novel class of Pt-II and Pt-IV pyridinehydroxamic acid (pyhaH) complexes of general formula cis-[(PtCl2)-Cl-II(x-pyhaH)(2)] and cis-[(PtCl4)-Cl-IV(x-pyhaH)(2)], respectively (where x = 3 or 4) in which the pyridinehydroxamic acid is coordinated to the platinum ion via the pyridine nitrogen only leaving the hydroxamic acid free to potentially release cytotoxic nitric oxide (NO). The crystal structure of the Pt-IV derivative, cis-[PtCl4(4-pyhaH)(2)]center dot 2CH(3)OH is reported. To establish the biological effect of the uncoordinated hydroxamic acid moiety in the Pt-II compounds synthesised, the corresponding pyridinecarboxylic acid (pycaH) complexes of general formula cis-[(PtCl2)-Cl-II(x-pycaH)(2)] (where x = 3 or 4) and the Nil pyridine (py) complex, cis-[(PtCl2)-Cl-II(py)(2)] were synthesised and served as reference standards. The NO-releasing properties of each of the Pt-II compounds, the pyhaH and the pycaH ligands were studied. The Pt-II pyridinehydroxamic acid derivatives were found to induce potent in vitro effects attributable to either NO-release from the hydroxamic acid moiety and/or stimulation of inducible nitric oxide synthase of endothelial cells. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.poly.2007.03.011
点击查看最新优质反应信息

文献信息

  • The synthesis, structure-toxicity relationship of cisplatin derivatives for the mechanism research of cisplatin-induced nephrotoxicity
    作者:Jing Hu、Tian-Ming Wu、Hong-Ze Li、Ze-Ping Zuo、Ying-Lan Zhao、Li Yang
    DOI:10.1016/j.bmcl.2017.04.077
    日期:2017.8
    Cisplatin is a widely used antineoplastic drug, while its nephrotoxicity limits the clinical application. Although several mechanisms contributing to nephrotoxicity have been reported, the direct protein targets are unclear. Herein we reported the synthesis of 29 cisplatin derivatives and the structure-toxicity relationship (STR) of these compounds with MTT assay in human renal proximal tubule cells (HK-2) and pig kidney epithelial cells (LLC-PK1). To the best of our knowledge, this study represented the first report regarding the structure-toxicity relationship (STR) of cisplatin derivatives. The potency of biotin-pyridine conjugated derivative 3 met the requirement for target identification, and the preliminary chemical proteomics results suggested that it is a promising tool for further target identification of cisplatin-induced nephrotoxicity. (C) 2017 Published by Elsevier Ltd.
  • Novel platinum pyridinehydroxamic acid complexes: Synthesis, characterisation, X-ray crystallographic study and nitric oxide related properties
    作者:Darren Griffith、Alberta Bergamo、Sara Pin、Marta Vadori、Helge Müller-Bunz、Gianni Sava、Celine J. Marmion
    DOI:10.1016/j.poly.2007.03.011
    日期:2007.10
    Herein, we describe the synthesis and characterisation of a novel class of Pt-II and Pt-IV pyridinehydroxamic acid (pyhaH) complexes of general formula cis-[(PtCl2)-Cl-II(x-pyhaH)(2)] and cis-[(PtCl4)-Cl-IV(x-pyhaH)(2)], respectively (where x = 3 or 4) in which the pyridinehydroxamic acid is coordinated to the platinum ion via the pyridine nitrogen only leaving the hydroxamic acid free to potentially release cytotoxic nitric oxide (NO). The crystal structure of the Pt-IV derivative, cis-[PtCl4(4-pyhaH)(2)]center dot 2CH(3)OH is reported. To establish the biological effect of the uncoordinated hydroxamic acid moiety in the Pt-II compounds synthesised, the corresponding pyridinecarboxylic acid (pycaH) complexes of general formula cis-[(PtCl2)-Cl-II(x-pycaH)(2)] (where x = 3 or 4) and the Nil pyridine (py) complex, cis-[(PtCl2)-Cl-II(py)(2)] were synthesised and served as reference standards. The NO-releasing properties of each of the Pt-II compounds, the pyhaH and the pycaH ligands were studied. The Pt-II pyridinehydroxamic acid derivatives were found to induce potent in vitro effects attributable to either NO-release from the hydroxamic acid moiety and/or stimulation of inducible nitric oxide synthase of endothelial cells. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-